Evan Marie Lowder

Evan Marie Lowder

Auto-generated profile, based on publicly available information

Evan Marie Lowder

George Mason University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2020 in Criminal Justice and Behavior
Verified
Journal Article
Closed access
PDF file
SDSarah L. Desmarais
Sarah L. Desmarais
SZSamantha A. Zottola
Samantha A. Zottola
SCSarah E. Duhart Clarke
Sarah E. Duhart Clarke
ELEvan M. Lowder
Evan M. Lowder
Bail reform is sweeping the nation and many jurisdictions are looking to pretrial risk assessment as one potential strategy to support these efforts. This article summarizes the findings of a systematic review of research examining the predictive validity of pretrial risk assessments. We reviewed 11 studies (13 publications) examining the predictive validity of six pretrial risk assessment instruments reported in the gray and peer-reviewed literature as of December, 2018. Findings typically show good to excellent predictive validity. Differences in predictive validity for men and women were mixed and small. When it could be examined, predictive validity was generally comparable across racial/ethnic subgroups; however, three comparisons revealed notably lower, albeit still fair to good, predictive validity for defendants of color than White defendants. Findings suggest that pretrial risk assessments predict pretrial outcomes with acceptable accuracy, but also emphasize the need for continued investigation of predictive validity across gender and racial/ethnic subgroups.

1 September 2018 in Midwifery
Verified
Journal Article
Closed access
BPBetty-Shannon Prevatt
Betty-Shannon Prevatt
ELEvan M. Lowder
Evan M. Lowder
SDSarah L. Desmarais
Sarah L. Desmarais

9 January 2020 in Journal of Epidemiology and Community Health
Verified
Journal Article
Open access
PDF file
ELEvan Marie Lowder
Evan Marie Lowder
JAJoseph Amlung
Joseph Amlung
BRBradley R Ray
Bradley R Ray
Background A lack of large-scale, individually linked data often has impeded efforts to disentangle individual-level variability in outcomes from area-level variability in studies of many diseases and conditions. This study investigated individual and county-level variability in outcomes following non-fatal overdose in a state-wide cohort of opioid overdose patients. Methods Participants were 24 031 patients treated by emergency medical services or an emergency department for opioid-involved overdose in Indiana between 2014 and 2017. Outcomes included repeat non-fatal overdose, fatal overdose and death. County-level predictors included sociodemographic, socioeconomic and treatment availability indicators. Individual-level predictors included age, race, sex and repeat non-fatal opioid-involved overdose. Multilevel models examined outcomes following non-fatal overdose as a function of patient and county characteristics. Results 10.9% (n=2612) of patients had a repeat non-fatal overdose, 2.4% (n=580) died of drug overdose and 9.2% (n=2217) died overall. Patients with a repeat overdose were over three times more likely to die of drug-related causes (OR=3.68, 99.9% CI 2.62 to 5.17, p<0.001). County-level effects were limited primarily to treatment availability indicators. Higher rates of buprenorphine treatment providers were associated with lower rates of mortality (OR=0.82, 95% CI 0.68 to 0.97, p=0.024), but the opposite trend was found for naltrexone treatment providers (OR=1.20, 95% CI 1.03 to 1.39, p=0.021). Cross-level interactions showed higher rates of Black deaths relative to White deaths in counties with high rates of naltrexone providers (OR=1.73, 95% CI 1.09 to 2.73, p=0.019). Conclusion Although patient-level differences account for most variability in opioid-related outcomes, treatment availability may contribute to county-level differences, necessitating multifaceted approaches for the treatment and prevention of opioid abuse.


28 July 2018 in Criminal Justice and Behavior
Verified
Journal Article
Closed access
ELEvan M. Lowder
Evan M. Lowder
MMMegan M. Morrison
Megan M. Morrison
DKDaryl G. Kroner
Daryl G. Kroner
SDSarah L. Desmarais
Sarah L. Desmarais
Risk assessments are now implemented in correctional settings across the United States as an evidence-based strategy to inform sentencing and supervision decisions. Despite growing research examining racial bias in the predictive validity of risk assessments, few studies have investigated racial bias in the context of judicial decision-making. We investigated the interactive contributions of race and Level of Service Inventory–Revised (LSI-R) risk assessments in predicting sentence length and probation outcomes in 11,792 Black and White probationers. Results showed White probationers at low-risk levels received longer sentences relative to Black probationers classified at the same risk levels. However, there were few differences at higher risk levels and no evidence of racial bias in the predictive accuracy of LSI-R assessments for other probation outcomes. Findings highlight the need for prospective and carefully controlled investigations into whether risk assessments improve the fairness and accuracy of sentencing and other risk management decisions.

6 July 2020 in Criminology & Public Policy
Verified
Journal Article
Closed access
PDF file
ELEvan M. Lowder
Evan M. Lowder
SLSpencer G. Lawson
Spencer G. Lawson
DODaniel O'DOnnell
Daniel O'DOnnell
ESEmily Sightes
Emily Sightes
BRBradley R. Ray
Bradley R. Ray
Research Summary: We conducted a retrospective, quasi‐experimental study of a police naloxone program to examine individual outcomes following nonfatal overdose where either police ( n = 111) or emergency medical services ( n = 1,229) provided a first response and administered naloxone. Individuals who received a police response were more likely to be arrested immediately following initial dispatch and had more instances of repeat nonfatal overdose two years following dispatch; there were no differences in rearrest or death rates. Findings suggest police naloxone programs may increase short‐term incarceration risk, but we found little evidence overall of long‐term adverse effects. Policy Implications: Naloxone is a tool to reduce fatal opioid‐involved overdose. Its provision alone does not constitute a comprehensive agency response to the opioid epidemic. Findings support the need for standardized policies and procedures to guide emergency responses to nonfatal overdose events and ensure consistency across agencies.